At a glance
Journal article in Oncoscience, 2014. Written by Nathalie Jacque and 1 co-authors. Institution: Institut Cochin, Département d'Immuno-Hématologie, CNRS UMR8104, INSERM U1016. Paris, France. Cited 6 times so far (Crossref). The full text is freely available in PubMed Central.
Abstract (original language)
Cancer cells require nutrients and energy to adapt to increased biosynthetic activity and depend on mitochondrial oxidative phosphorylation (OXPHOS) and glycolysis. Whereas they exhibit a pronounced Warburg effect, their TCA cycle remains intact and becomes more dependent on glutamine metabolism through glutaminolysis[1]. Besides this role, intracellular glutamine is also essential for mTORC1 activation by leucine[2]. Many upstream signals regulate mTORC1 activation. Among them, a major process is the availability of leucine, which is required to activate the Rag (for Ras-related GTPases) proteins that enable the proper localization of mTORC1 at the lysosome surface close to its activator Rheb[3]. Leucine uptake into the cells is regulated by the bidirectional transporter
Authors and institutions
- Institut Cochin, Département d'Immuno-Hématologie, CNRS UMR8104, INSERM U1016. Paris, France.
- Unité Fonctionnelle d'Hématologie, Hôpital Cochin, AP-HP. Paris, France. ; Institut Cochin, Département d'Immuno-Hématologie, CNRS UMR8104, INSERM U1016. Paris, France. ; Université Paris Descartes, Faculté de Médecine…
Cite
APA
Jacque, N., & Bouscary, D. (2014). Targeting glutamine uptake in AML. Oncoscience. https://doi.org/10.18632/oncoscience.1
Vancouver
Jacque N, Bouscary D. Targeting glutamine uptake in AML. Oncoscience. 2014. doi:10.18632/oncoscience.1
BibTeX
@article{Jacque2014,
author = {Jacque, Nathalie and Bouscary, Didier},
title = {Targeting glutamine uptake in AML},
journal = {Oncoscience},
year = {2014},
doi = {10.18632/oncoscience.1}
}
EUVIMED